Physician profile
Krishna Akella
NPI 1982067211
$14,062.17
in general payments reported to CMS, 2019-2025
5 companies · $2,750 in 2025
The $2,750 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $11K · 2025: $2,750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Food and Beverage: $1,752 · Travel and Lodging: $1,512 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,657.35 |
| Food and Beverage | $1,751.61 |
| Travel and Lodging | $1,511.51 |
| Education | $141.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,341.25 | 2024-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $6,499.31 | 2024 | Tacticath Ablation Catheter, Sensor Enabled, Assurity, Ensite Precision |
| Boston Scientific Corporation | $154.04 | 2024-2025 | Ams 700, Watchman Access System, Farapulse |
| Edwards Lifesciences Corporation | $49.16 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Novartis Pharmaceuticals Corporation | $18.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Akella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.